Pharmacological inhibition of glycogen phosphorylase (GP) lowers plasma glucose in rat models of type 2 diabetes

被引：0
|
作者：
Turnbull, A
Fraser, J
Loxham, S
Teague, J
Ellershaw, L
Roberts, D
Mayers, R
Walker, M
Evans, J
Freeman, S
Poucher, S
Carey, F
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A343 / A343
页数：1
相关论文
共 50 条
  • [21] Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes
    Joseph M. Hayes
    Anastassia L. Kantsadi
    Demetres D. Leonidas
    Phytochemistry Reviews, 2014, 13 : 471 - 498
  • [22] Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes
    Hayes, Joseph M.
    Kantsadi, Anastassia L.
    Leonidas, Demetres D.
    PHYTOCHEMISTRY REVIEWS, 2014, 13 (02) : 471 - 498
  • [23] The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction
    Baker, David J.
    Greenhaff, Paul L.
    MacInnes, Alan
    Timmons, James A.
    DIABETES, 2006, 55 (06) : 1855 - 1861
  • [24] Genetic and pharmacological inhibition of vanin-1 activity in animal models of type 2 diabetes
    Janna A. van Diepen
    Patrick A. Jansen
    Dov B. Ballak
    Anneke Hijmans
    Floris P.J.T. Rutjes
    Cees J. Tack
    Mihai G. Netea
    Joost Schalkwijk
    Rinke Stienstra
    Scientific Reports, 6
  • [25] Genetic and pharmacological inhibition of vanin-1 activity in animal models of type 2 diabetes
    van Diepen, Janna A.
    Jansen, Patrick A.
    Ballak, Dov B.
    Hijmans, Anneke
    Rutjes, Floris P. J. T.
    Tack, Cees J.
    Netea, Mihai G.
    Schalkwijk, Joost
    Stienstra, Rinke
    SCIENTIFIC REPORTS, 2016, 6
  • [26] Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model
    Sociali, Giovanna
    Magnone, Mirko
    Ravera, Silvia
    Damonte, Patrizia
    Vigliarolo, Tiziana
    Von Holtey, Maria
    Vellone, Valerio G.
    Millo, Enrico
    Caffa, Irene
    Cea, Michele
    Parenti, Marco Daniele
    Del Rio, Alberto
    Murone, Maximilien
    Mostoslavsky, Raul
    Grozio, Alessia
    Nencioni, Alessio
    Bruzzone, Santina
    FASEB JOURNAL, 2017, 31 (07): : 3138 - 3149
  • [27] Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model
    Sociali, G.
    Magnone, M.
    Ravera, S.
    Damonte, P.
    Von Holtey, M.
    Millo, E.
    Caffa, I.
    Cea, M.
    Parenti, M. D.
    Del Rio, A.
    Murone, M.
    Grozio, A.
    Vellone, V. G.
    Vigliarolo, T.
    Nencioni, A.
    Bruzzone, S.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 80 - 80
  • [28] Inhibition of lipolysis in Type 2 diabetes normalizes glucose disposal without change in muscle glycogen synthesis rates
    Lim, Ee L.
    Hollingsworth, Kieren G.
    Smith, Fiona E.
    Thelwall, Peter E.
    Taylor, Roy
    CLINICAL SCIENCE, 2011, 121 (3-4) : 169 - 177
  • [29] Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
    Fonseca, Vivian A.
    Handelsman, Yehuda
    Staels, Bart
    DIABETES OBESITY & METABOLISM, 2010, 12 (05): : 384 - 392
  • [30] Recombinant Adiponectin Does Not Lower Plasma Glucose in Animal Models of Type 2 Diabetes
    Tullin, Soren
    Sams, Anette
    Brandt, Jakob
    Dahl, Kirsten
    Gong, Wei
    Jeppesen, Claus Bekker
    Krogh, Thomas Nylandsted
    Olsen, Grith Skytte
    Liu, Yun
    Pedersen, Anette Amstrup
    Petersen, Jorn Meidahl
    Rolin, Bidda
    Wahlund, Per-Olof
    Kalthoff, Christoph
    PLOS ONE, 2012, 7 (10):
12345